Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

IMPORTANCE: Neuropsychiatric symptoms are commonly encountered and are highly debilitating in patients with Alzheimer disease. Understanding their underpinnings has implications for identifying biomarkers and treatment for these symptoms. OBJECTIVE: To evaluate whether glial markers are associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaffer Aguzzoli, Cristiano, Ferreira, Pâmela C. L., Povala, Guilherme, Ferrari-Souza, João Pedro, Bellaver, Bruna, Soares Katz, Carolina, Zalzale, Hussein, Lussier, Firoza Z., Rohden, Francieli, Abbas, Sarah, Leffa, Douglas T., Scop Medeiros, Marina, Therriault, Joseph, Benedet, Andréa L., Tissot, Cécile, Servaes, Stijn, Rahmouni, Nesrine, Cassa Macedo, Arthur, Bezgin, Gleb, Kang, Min Su, Stevenson, Jenna, Pallen, Vanessa, Cohen, Ann, Lopez, Oscar L., Tudorascu, Dana L., Klunk, William E., Villemagne, Victor L., Soucy, Jean Paul, Zimmer, Eduardo R., Schilling, Lucas P., Karikari, Thomas K., Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Gauthier, Serge, Valcour, Victor, Miller, Bruce L., Rosa-Neto, Pedro, Pascoal, Tharick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682836/
https://www.ncbi.nlm.nih.gov/pubmed/38010651
http://dx.doi.org/10.1001/jamanetworkopen.2023.45175

Ejemplares similares

Ejemplares similares